asthma

By Laura Lovett November 16, 2017
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest respiratory digital health deployment with a pharmacy benefit manager yet.  The Propeller system allows a patients to attach a sensor to their inhaler, which is synced to an app on the users smart phone....
By Dave Muoio November 2, 2017
North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with a mobile app can be used to verify dose delivery in real-time. “What we’ve done is created the first electronically breath-actuated inhaler,” James Bauler, VP of business development at Pneuma...
By Dave Muoio October 10, 2017
Madison, Wisconsin-based Propeller Health is taking its asthma alert messaging to the masses, as the longtime digital respiratory health company announced today that it is releasing Air, a free and open API that provides information on local asthma conditions. Air makes asthma forecasts by pulling geographic data on humidity, wind direction, temperature, and other pollutants collected by the...
By Jeff Lagasse September 1, 2017
Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, dubbed the SmartTouch for Symbicort.   The SmartTouch is a device that grafts onto a patient’s inhaler to monitor and encourage medication adherence as...
By Jeff Lagasse August 24, 2017
Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for, and undertake, commercial activities using the Propeller clip-on sensor and software platform for use with GSK’s ELLIPTA Inhaler.   Ongoing research and development efforts will continue, with...
By Jonah Comstock June 21, 2017
Madison, Wisconsin-based Propeller Health is now a decade old. The digital health company, which makes connected inhalers and patient- and provider-facing data analytics tools for respiratory diseases asthma and COPD, can hardly be considered a startup anymore. Nowadays the company has numerous published efficacy studies and business relationships with most major pharma companies in the...
By Heather Mack April 18, 2017
Dublin, Ohio-based Monitored Therapeutics, Inc. (MTI) has received FDA 510(k) clearance for its connected spirometer, GoSpiro. The device, which calculates diagnostic-quality air capacity measurement, was designed specifically for use in a non-clinical setting. As calculations are performed inside the device, GoSpiro can work with any smartphone, tablet or computer without the need for separate...
By Heather Mack March 15, 2017
New York City-based Cohero Health, which develops connected health tools and technologies for chronic respiratory diseases, has closed on $10.5 million in Series A funding. This builds on the company’s earlier $9 million Series A round from late 2016, and the extra funding comes from new strategic investors Samsung Next and Omron Healthcare. With seed funding, this brings Cohero's total funding...
By Heather Mack March 13, 2017
A new study demonstrates that conducting some studies entirely via smartphones is feasible, fruitful and scalable: it stands up to scientific rigor, allows for large-scale participant enrollment,and captures unique environmental data not available through traditional methods, as researchers at the Icahn School of Medicine at Mount Sinai have learned. In a new article published today in the...
By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...